GlassScriptPhysician profile
Amanda A Hussein
NPI 1518528124
$241.29
in general payments reported to CMS, 2019-2025
9 companies · $29.10 in 2025
The $29.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.63 · 2020: $37.13 · 2024: $160 · 2025: $29.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $65.46 | 2024 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $30.28 | 2024 | Airsupra |
| Medtronic, INC. | $29.10 | 2025 | Hawkone |
| Sumitomo Pharma America, INC. | $25.85 | 2024 | Gemtesa |
| Gilead Sciences, INC. | $24.13 | 2020 | |
| Abbott Laboratories | $19.81 | 2024 | Freestyle Libre 3 |
| Lilly USA, LLC | $19.03 | 2024 | Zepbound |
| Janssen Pharmaceuticals, INC | $14.63 | 2019 | |
| Pfizer INC. | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hussein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.